|
|
Volumn 48, Issue 1, 2012, Pages 33-77
|
|
The year's new drugs & biologics, 2011
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALISKIREN PLUS AMLODIPINE PLUS HYDROCHLOROTHIAZIDE;
ALOGLIPTIN BENZOATE PLUS PIOGLITAZONE;
ANTIDIABETIC AGENT;
APIXABAN;
AVANAFIL;
AZFICEL T;
AZILSARTAN MEDOXOMIL;
AZILSARTAN MEDOXOMIL PLUS CHLORTALIDONE;
BETANIS;
BILASTINE;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
BUPIVACAINE;
CHLORTALIDONE;
CLONIDINE;
DEXTROMETHORPHAN PLUS QUINIDINE;
ECULIZUMAB;
EDARBYCLOR;
EDOXABAN TOSILATE HYDRATE;
EXENDIN 4;
GABAPENTIN ENACARBIL;
GLUBES;
LINAGLIPTIN;
LIOVEL;
LIXIANA;
LURASIDONE;
MANNITOL;
MIRABEGRON;
RETIGABINE;
RIVAROXABAN;
SIMVASTATIN PLUS SITAGLIPTIN;
TADALAFIL;
TAFAMIDIS;
TICAGRELOR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VILAZODONE;
ZEPEED;
ACTINIC KERATOSIS;
ALLERGIC RHINITIS;
AMYOTROPHIC LATERAL SCLEROSIS;
ANALGESIA;
ANESTHESIA;
ATTENTION DEFICIT DISORDER;
CANCER CHEMOTHERAPY;
CHRONIC URTICARIA;
CONNECTIVE TISSUE DISEASE;
CONSTIPATION;
CYSTIC FIBROSIS;
DIAGNOSTIC PROCEDURE;
DIARRHEA;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
DRUG TOLERABILITY;
EMBOLISM;
ERECTILE DYSFUNCTION;
FAMILIAL AMYLOID POLYNEUROPATHY;
FOOD AND DRUG ADMINISTRATION;
GLYCEMIC CONTROL;
HEART ATRIUM FIBRILLATION;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
HYPERTENSION;
IMMUNIZATION;
IMMUNOMODULATION;
MAJOR DEPRESSION;
MULTICENTER STUDY (TOPIC);
MULTIPLE SCLEROSIS;
MUSCULOSKELETAL DISEASE;
NAUSEA AND VOMITING;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OVERACTIVE BLADDER;
PAIN;
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PROSTATE HYPERTROPHY;
PSEUDOBULBAR PALSY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RESTLESS LEGS SYNDROME;
REVIEW;
SCHIZOPHRENIA;
SEIZURE;
STROKE;
THROMBOSIS;
THROMBOSIS PREVENTION;
TOTAL HIP PROSTHESIS;
TOTAL KNEE REPLACEMENT;
URINARY URGENCY;
URINE INCONTINENCE;
VENOUS THROMBOEMBOLISM;
VIRUS INFECTION;
BIOLOGICAL AGENTS;
DRUG APPROVAL;
DRUG DESIGN;
DRUG INDUSTRY;
DRUGS, GENERIC;
HUMANS;
ORPHAN DRUG PRODUCTION;
PHARMACEUTICAL PREPARATIONS;
UNITED STATES;
|
|
EID: 84857675356
PISSN: 16993993
EISSN: 16994019
Source Type: Journal
DOI: 10.1358/dot.2012.48.1.1769676 Document Type: Review |
|
Times cited : (14)
|
|
References (5)
|
